Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 9Triple Negative Breast Neoplasms 3Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Non-small Cell Lung Cancer Metastatic 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Meningioma 1Melanoma 1Lymphoma 1Fallopian Tube Neoplasms 1Exanthema 1Endometrial Neoplasms 1Disease Progression 1Diarrhea 1Chondrosarcoma 1Carcinoma, Squamous Cell 1CCCA Assessed by Ki67 Drop Below <2.7% From Baseline 1Advanced Gastric Cancer 1Advanced Cancer 1Advanced Breast Cancer 1

Interventions

Filgrastim 4Proton Therapy 3Docetaxel 3regorafenib 2Sunitinib 2Ifosfamide 2Gemcitabine 2Carboplatin 2temsirolimus 1pegfilgrastim 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1ivosidenib 1itacitinib 1etoposide phosphate 1capivasertib 1baricitinib 1apatinib 1angiotensin I (1-7) 1abemaciclib 1Zoledronic Acid 1Weight-Bearing 1Trabectedin 1Topotecan 1Thiotepa 1Thalidomide 1Taxes 1TQ-B3525 1Surveys and Questionnaires 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chondrosarcoma × capivasertib × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡